Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | BG5J4 | IM / AR |
PATIENT DID NOT REPORT ANY ADVERSE EVENTS OR EFFECTS RELEATED TO THE VACCINE; THIS WAS A DUPLICATE VACCINE AS THE PATIENT HAD RECIEVED IN APRIL OF 2024 AND IT IS ONLY INDICATED 1/LIFETIME
PROPRANOLOL, TERBINAFINE, TADALFIL, TOPIRIMATE, OMEPRAZOLE, CLOBETASOL
NKDA